How Technology Is Driving Adoption of Pharmacogenomics Sherin Shaaban, MD, PhD, FACMG, explains how progress in instruments, methods, and other areas has influenced uptake of PGx testing. Learn More
Progress on Pharmacogenomics Becoming the Standard of Cancer Care Peter H. O'Donnell, MD, discusses how PGx has already changed oncology, and how it will transform therapeutic practice in the future. Learn More